P. Sevelda

6.3k total citations
137 papers, 2.7k citations indexed

About

P. Sevelda is a scholar working on Reproductive Medicine, Oncology and Surgery. According to data from OpenAlex, P. Sevelda has authored 137 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Reproductive Medicine, 45 papers in Oncology and 29 papers in Surgery. Recurrent topics in P. Sevelda's work include Ovarian cancer diagnosis and treatment (54 papers), Breast Cancer Treatment Studies (21 papers) and Intraperitoneal and Appendiceal Malignancies (16 papers). P. Sevelda is often cited by papers focused on Ovarian cancer diagnosis and treatment (54 papers), Breast Cancer Treatment Studies (21 papers) and Intraperitoneal and Appendiceal Malignancies (16 papers). P. Sevelda collaborates with scholars based in Austria, Germany and United Kingdom. P. Sevelda's co-authors include Andreas Obermair, Heinrich Salzer, M. Schemper, K. Czerwenka, M. Medl, C Peters-Engl, Alexandra Kaider, N. Vavra, Joos Vandewalle and Anthony Fyles and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

P. Sevelda

134 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Sevelda Austria 26 1.1k 906 723 593 482 137 2.7k
Philippe Moerman Belgium 31 1.3k 1.1× 772 0.9× 459 0.6× 1.9k 3.1× 606 1.3× 125 3.6k
Takahiro Kasamatsu Japan 28 873 0.8× 544 0.6× 865 1.2× 1.1k 1.8× 191 0.4× 122 2.6k
Lisa M. Landrum United States 24 1.1k 0.9× 829 0.9× 710 1.0× 1.4k 2.3× 348 0.7× 87 2.9k
Joseph T. Rabban United States 36 1.2k 1.0× 706 0.8× 581 0.8× 1.1k 1.9× 610 1.3× 116 3.5k
Edward J. Tanner United States 31 1.2k 1.1× 547 0.6× 774 1.1× 1.6k 2.7× 397 0.8× 111 3.1k
Jean Lévêque France 24 400 0.3× 478 0.5× 610 0.8× 545 0.9× 606 1.3× 142 2.2k
Giacomo Corrado Italy 34 1.5k 1.3× 512 0.6× 1.1k 1.5× 1.8k 3.0× 293 0.6× 179 3.3k
Otto Ljungberg Sweden 30 377 0.3× 1.2k 1.3× 784 1.1× 166 0.3× 407 0.8× 102 3.3k
Giorgia Mangili Italy 35 2.4k 2.1× 529 0.6× 1.1k 1.5× 1.4k 2.3× 153 0.3× 211 4.0k
Yoo-Young Lee South Korea 32 748 0.7× 630 0.7× 1.1k 1.5× 1.2k 2.0× 396 0.8× 158 3.0k

Countries citing papers authored by P. Sevelda

Since Specialization
Citations

This map shows the geographic impact of P. Sevelda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Sevelda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Sevelda more than expected).

Fields of papers citing papers by P. Sevelda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Sevelda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Sevelda. The network helps show where P. Sevelda may publish in the future.

Co-authorship network of co-authors of P. Sevelda

This figure shows the co-authorship network connecting the top 25 collaborators of P. Sevelda. A scholar is included among the top collaborators of P. Sevelda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Sevelda. P. Sevelda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bjelic‐Radisic, Vesna, Christian F. Singer, Karl Tamussino, et al.. (2019). Contralateral prophylactic mastectomy in women with breast cancer without a family history or genetic predisposition. Wiener klinische Wochenschrift. 131(9-10). 233–236. 1 indexed citations
2.
Krzemieniecki, Krzysztof, P. Sevelda, Frans Erdkamp, et al.. (2013). Neutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy—findings from clinical practice. Supportive Care in Cancer. 22(3). 667–677. 25 indexed citations
3.
Marth, Christian, et al.. (2009). Influence of Department Volume on Survival for Ovarian Cancer: Results From a Prospective Quality Assurance Program of the Austrian Association for Gynecologic Oncology. International Journal of Gynecological Cancer. 19(1). 94–102. 42 indexed citations
4.
Vutuc, Christian, Thomas Waldhoer, P. Sevelda, M. Micksche, & Gerald Haidinger. (2007). Self-Reported Opportunistic Screening Mammography in Austria – 2005 vs. 1995. Breast Care. 2(5). 313–316. 5 indexed citations
5.
Schernhammer, Eva, et al.. (2005). Phase I/II study of oral etoposide plus GM-CSF as second-line chemotherapy in platinum-pretreated patients with advanced ovarian cancer. British Journal of Cancer. 92(6). 1019–1025. 10 indexed citations
6.
Peters-Engl, C, et al.. (2001). Lunar phases and survival of breast cancer patients – a statistical analysis of 3,757 cases. Breast Cancer Research and Treatment. 70(2). 131–135. 24 indexed citations
7.
Nagele, Fritz, et al.. (1996). CA 125 als Prognosefaktor für das Überleben bei Patientinnen mit epithelialen Ovarialkarzinomen des FIGO-Stadium I - preliminäre Ergebnisse. Geburtshilfe und Frauenheilkunde. 56(2). 79–82. 4 indexed citations
8.
Hausmaninger, H., M. Lehnert, Guenther G. Steger, et al.. (1995). Randomised phase II study of epirubicin-vindesine versus mitoxantrone-vindesine in metastatic breast cancer. European Journal of Cancer. 31(13-14). 2169–2173. 9 indexed citations
9.
Sevelda, P., Michael Klein, A. Graf, et al.. (1994). A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer. British Journal of Cancer. 69(3). 577–579. 25 indexed citations
10.
Obermair, Andreas, et al.. (1994). Tumoral vascular density in breast tumors and their effect on recurrence-free survival Tumorale Gefässdichte bei Mammatumoren und ihr Einfluss auf das rezidivfreie Uberleben. Queensland's institutional digital repository (The University of Queensland). 65(7). 611–615. 1 indexed citations
11.
Obermair, Andreas, et al.. (1994). Tumor Microvessel Density in Breast-Cancer and its Influence On Recurrence-Free Survival - Reply. Queensland's institutional digital repository (The University of Queensland). 65(1). 611–615. 11 indexed citations
12.
Obermair, Andreas, et al.. (1994). Influence of Tumoral Microvessel Density on the Recurrence-Free Survival in Human Breast Cancer: Preliminary Results. Oncology Research and Treatment. 17(1). 44–49. 17 indexed citations
13.
Czerwenka, K., H Hanak, Sepp Leodolter, et al.. (1993). HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samples. European Journal of Cancer. 29(11). 1593–1597. 20 indexed citations
14.
15.
Vavra, N., H. Kucera, Ursula Denison, et al.. (1992). Nicotine Abuse as a Prognostic Factor in Stage Ib Cervical Carcinoma. Oncology Research and Treatment. 15(4). 295–299. 1 indexed citations
16.
Sevelda, P., et al.. (1990). Ist die Verlaufskontrolle falsch negativer CA-125 Serumwerte in der Tumornachsorge des Ovarialkarzinoms sinnvoll?. Gyn�kologisch-geburtshilfliche Rundschau. 30(1). 210–211. 2 indexed citations
17.
Vavra, N., Helmut J.F. Salzer, P. Sevelda, et al.. (1990). Adjuvante Hormontherapie beim Endometriumkarzinom: Medroxyprogesteronazetat-versus Tamoxifen-Medroxyprogesteronazetat-Sequenztherapie. Gyn�kologisch-geburtshilfliche Rundschau. 30(3). 133–143. 2 indexed citations
18.
Vavra, N., et al.. (1990). [Goserelin--a new form of hormone therapy in ovarian cancer].. PubMed. 30 Suppl 1. 61–3. 2 indexed citations
19.
Sevelda, P., et al.. (1989). Sectio versus vaginale Entbindung der Beckenendlage bei Primiparae. Gyn�kologisch-geburtshilfliche Rundschau. 29(2). 319–320. 2 indexed citations
20.
Hausmaninger, H., M. Lehnert, G.G. Steger, et al.. (1989). Vindesine-Epirubicin versus Vindesine-Mitoxantrone in Metastatic Breast Cancer. Oncology Research and Treatment. 12(5). 225–229. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philippe Moerman Breakdown of academic impact, for papers by Takahiro Kasamatsu Breakdown of academic impact, for papers by Lisa M. Landrum Breakdown of academic impact, for papers by Joseph T. Rabban Breakdown of academic impact, for papers by Edward J. Tanner Breakdown of academic impact, for papers by Jean Lévêque Breakdown of academic impact, for papers by Giacomo Corrado Breakdown of academic impact, for papers by Otto Ljungberg Breakdown of academic impact, for papers by Giorgia Mangili Breakdown of academic impact, for papers by Yoo-Young Lee
Rankless by CCL
2026